55 related articles for article (PubMed ID: 19695572)
1. Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia.
Moret M; Pruneta-Deloche V; Sassolas A; Marcais C; Moulin P
Atherosclerosis; 2010 Feb; 208(2):324-7. PubMed ID: 19695572
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a new case of autoimmune type I hyperlipidemia: long-term remission under immunosuppressive therapy.
Pruneta V; Moulin P; Labrousse F; Bondon PJ; Ponsin G; Berthezene F
J Clin Endocrinol Metab; 1997 Mar; 82(3):791-6. PubMed ID: 9062484
[TBL] [Abstract][Full Text] [Related]
3. Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.
Pruneta-Deloche V; Marçais C; Perrot L; Sassolas A; Delay M; Estour B; Lagarde M; Moulin P
J Clin Endocrinol Metab; 2005 Jul; 90(7):3995-8. PubMed ID: 15840743
[TBL] [Abstract][Full Text] [Related]
4. Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer.
Liu G; Excoffon KJ; Wilson JE; McManus BM; Miao L; Benoit P; Duverger N; Branellec D; Denefle P; Hayden MR; Lewis ME
Clin Invest Med; 1998; 21(4-5):172-85. PubMed ID: 9800066
[TBL] [Abstract][Full Text] [Related]
5. [Autoimmune hyperchylomicronemia].
Nozaki S; Matsuzawa Y
Nihon Rinsho; 1999 Dec; 57(12):2765-9. PubMed ID: 10638210
[TBL] [Abstract][Full Text] [Related]
6. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
Kodera M; Hayakawa I; Komura K; Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
[TBL] [Abstract][Full Text] [Related]
8. The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood.
Kwiterovich PO; Farah JR; Brown WV; Bachorik PS; Baylin SB; Neill CA
Pediatrics; 1977 Apr; 59(4):513-25. PubMed ID: 191790
[TBL] [Abstract][Full Text] [Related]
9. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
10. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
Brunzell JD; Hazzard WR; Porte D; Bierman EL
J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
[TBL] [Abstract][Full Text] [Related]
12. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
13. Absence of N-glycosylation at asparagine 43 in human lipoprotein lipase induces its accumulation in the rough endoplasmic reticulum and alters this cellular compartment.
Buscá R; Pujana MA; Pognonec P; Auwerx J; Deeb SS; Reina M; Vilaró S
J Lipid Res; 1995 May; 36(5):939-51. PubMed ID: 7658166
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
Kashyap ML; Srivastava LS; Chen CY; Perisutti CG; Campbell M; Lutmer RF; Glueck CJ
J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune hyperchylomicronemia.
Kihara S; Matsuzawa Y; Kubo M; Nozaki S; Funahashi T; Yamashita S; Sho N; Tarui S
N Engl J Med; 1989 May; 320(19):1255-9. PubMed ID: 2785243
[No Abstract] [Full Text] [Related]
16. Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia.
Beaumont JL; Berard M; Antonucci M; Delplanque B; Vranckx R
Atherosclerosis; 1977 Jan; 26(1):67-77. PubMed ID: 836349
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein lipase gene mutations in coronary artery disease.
Minnich A; Baloukas J; Roederer G; Lussier-Cacan S; Davignon J; Genest J
Can J Cardiol; 1998 May; 14(5):711-6. PubMed ID: 9627528
[TBL] [Abstract][Full Text] [Related]
18. Unusual metabolic characteristics in skeletal muscles of transgenic rabbits for human lipoprotein lipase.
Gondret F; Jadhao SB; Damon M; Herpin P; Viglietta C; Houdebine LM; Hocquette JF
Lipids Health Dis; 2004 Dec; 3():27. PubMed ID: 15588304
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of lipoprotein lipolysis by polyarginine and evaluation of the mechanism of its interaction with lipoprotein lipase].
Klimov AN; Serrano DS; Kliueva NN; Soliternova IB; Nikul'cheva NG
Biokhimiia; 1985 May; 50(5):804-13. PubMed ID: 4005323
[TBL] [Abstract][Full Text] [Related]
20. In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation.
Takahashi M; Hiyama Y; Yokoyama M; Yu S; Hu Y; Melford K; Bensadoun A; Goldberg IJ
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):455-62. PubMed ID: 18258818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
